Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.13
-0.8924-1.44%
Volume:7K
Turnover:444.15K
Market Cap:287.31M
PE:20.00
High:62.20
Open:62.20
Low:60.99
Close:62.02
52wk High:64.10
52wk Low:39.76
Shares:4.70M
Float Shares:4.70M
Volume Ratio:0.27
T/O Rate:0.15%
Dividend:1.53
Dividend Rate:2.50%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Reuters
·
Sep 03

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Deep News
·
Sep 02

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Dow Jones
·
Sep 02

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

Stock News
·
Sep 02

港股动态:今海医疗科技股价攀升逾4%,中期收益激增逾1.3倍,核心业务向高附加值医疗器械领域转型

Stock News
·
Sep 02

Roivant Sciences President, Immunovant CEO Eric Venker Disposes of Common Shares Worth $7.15 Million

Reuters
·
Sep 02

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

TIPRANKS
·
Sep 02

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Reuters
·
Sep 01

Tellgen Corporation Secures Six New Medical Device Approvals

Stock News
·
Sep 01

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

Deep News
·
Sep 01

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

TIPRANKS
·
Sep 01

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.
·
Sep 01

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Stock News
·
Sep 01

Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage

Simply Wall St.
·
Sep 01

NASD Most Active Issues

Dow Jones
·
Sep 01

Axsome pullback brings attractive entry point, says H.C. Wainwright

TIPRANKS
·
Aug 31

Axsome Therapeutics, - Doses First Patient in Summit Phase 3 Trial of Axs-05 for Smoking Cessation

THOMSON REUTERS
·
Aug 31

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

GlobeNewswire
·
Aug 31

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS
·
Aug 31